Worlds biggest
manufacturers
of bacteriophages
MORE THAN 10 YEARS OF SUCCESSFUL TRACK RECORD
OUR GLOBAL NETWORK
.svg)
We prioritize efficiency to ensure your projects are completed on time, every time.
Our team keeps you informed at every stage with open and straightforward communication.
We align every step of the process to meet your deadlines with accuracy and reliability.
Our services are designed to deliver maximum value without compromising on quality.
From small batches to large-scale manufacturing, we offer GMP-compliant solutions tailored to your needs.
CONTRACT RESEARCH & MANUFACTURING PARTNER
our certificates
JAFRAL CEO to speak at GAMRIC 2026 in Lisbon
Dr. Smrekar will join a panel discussion titled "Phage therapy as a narrow-spectrum antimicrobial strategy: from product concept to late-stage clinical development," addressing one of the most pressing challenges in the fight against antimicrobial resistance: how to move precision, narrow-spectrum therapies such as bacteriophages from early-stage product concepts through to late-stage clinical development.
GAMRIC brings together leading researchers, clinicians, policymakers, and industry innovators from around the world to advance the global response to antimicrobial resistance (AMR). JAFRAL's participation reflects our ongoing commitment to developing sustainable, targeted therapeutic solutions that address AMR without disrupting the wider microbiome.
Visitors to the conference are also invited to stop by our roll-up display on Magistral Phage Therapy, on-site throughout the event.
We look forward to engaging with the global AMR community in Lisbon and sharing Jafral's perspective on the future of narrow-spectrum antimicrobial development.
